Clinical trial
A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes
NCT04902573 is registered in ClinicalTrials.gov with Chiesi UK as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes
- Lead sponsor
- Chiesi UK
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 17, 2021
- Completion date
- June 14, 2024
- Enrollment
- 147 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.